Stay updated on Baricitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Atopic Dermatitis Clinical Trial page
- ChecktodayChange DetectedA sitewide banner announces NIH website transition updates and says NIH is adopting “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check7 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study content and navigation and effectively blocking access to the study details.SummaryDifference18%

- Check56 days agoChange DetectedAdded Revision: v3.6.6 and removed Revision: v3.6.5, reflecting a minor update to the page’s revision history.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now includes the official study title, sponsor, IPD sharing details, and links to key documents and resources, consolidating the study's documentation and data-access information.SummaryDifference90%

Stay in the know with updates to Baricitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Atopic Dermatitis Clinical Trial page.